Search results
Results from the WOW.Com Content Network
David H. Raulet is an American immunologist who specializes in studying the role of natural killer cells.He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology. [1]
For premium support please call: 800-290-4726 more ways to reach us
Crowley left Genzyme to ensure that his children would qualify for a drug developed by the company. He then became founding president and CEO of Orexigen Therapeutics in 2003. In 2004, he became a director at Amicus Therapeutics, based in Cranbury, New Jersey, and in January 2005, he was named the president and CEO of the company. [17]
John Mendlein is a biotech executive who has held leadership positions in biotech companies in Boston, San Diego and Toronto. [1]Mendlein served as a board member, general counsel and chief knowledge officer at Aurora Biosciences Corporation (Nasdaq: ABSC), a company co-founded by Nobel laureate Roger Y. Tsien and since acquired by Vertex Pharmaceuticals (Nasdaq: VRTX) for more than $590 million.
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 and will serve as an adviser till June 30, the company said. Prior to Summit ...
Executives Jared Birchall. ... Seo is a founding member of the Neuralink team. Nir Even-Chen. Head of brain interfaces applications A former senior research scientist at Lyft. Shivon Zilis.
Dietrich A. Stephan (born August 25, 1969) is an American human geneticist and entrepreneur who works in personalized medicine. Stephan is currently CEO of NeuBase Therapeutics [1] and a General Partner in Cyto Ventures.